We are live on ! Find out more
HPCM

High Pointe Capital Management Portfolio holdings

AUM $139M
1-Year Est. Return 24.99%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
AUM
$70.1M
AUM Growth
-$2.65M
Cap. Flow
-$4.75M
Cap. Flow %
-6.77%
Top 10 Hldgs %
26.21%
Holding
92
New
5
Increased
4
Reduced
38
Closed
11

Top Sells

Rank Stock Value
1
JLL icon
Jones Lang LaSalle
JLL
+$1.34M
2
SBUX icon
Starbucks
SBUX
+$1.28M
3
SRE icon
Sempra
SRE
+$1.15M
4
ZTS icon
Zoetis
ZTS
+$1M
5
AAPL icon
Apple
AAPL
+$819K

Sector Composition

Rank Sector Weight
1 Healthcare 20.02%
2 Financials 18.24%
3 Technology 11.59%
4 Communication Services 9.9%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYG icon
76
Lloyds Banking Group
LYG
$85.2B
$178K 0.25%
53,550
-1,150
-2% -$4.09K
ODP
77
DELISTED
ODP
ODP
$26K 0.04%
+1,029
New +$25K
AAPL icon
78
Apple
AAPL
$4.97T
-19,516
Closed -$819K
CIB icon
79
Grupo Cibest SA
CIB
$21.2B
-6,180
Closed -$260K
INFY icon
80
Infosys
INFY
$51B
-30,610
Closed -$273K
JLL icon
81
Jones Lang LaSalle
JLL
$15.8B
-7,660
Closed -$1.34M
MAT icon
82
Mattel
MAT
$4.47B
-19,300
Closed -$254K
PEP icon
83
PepsiCo
PEP
$196B
-4,820
Closed -$526K
SBUX icon
84
Starbucks
SBUX
$119B
-22,096
Closed -$1.28M
SRE icon
85
Sempra
SRE
$58.1B
-20,760
Closed -$1.15M
TV icon
86
Televisa
TV
$1.49B
-12,690
Closed -$203K
ZTS icon
87
Zoetis
ZTS
$32.7B
-11,970
Closed -$1M

Similar funds

High Pointe Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, High Pointe Capital Management held 92 positions worth $70.1M, down 3.6% from $72.8M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

High Pointe Capital Management withdrew a net $4.75M in Q2 2018, closing 11 positions and reducing 38 holdings. Its most notable exit was Jones Lang LaSalle, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

Against the trend, High Pointe Capital Management opened a new position in Regeneron Pharmaceuticals worth $862K.

  • High Pointe Capital Management's largest Q2 2018 buy was Regeneron Pharmaceuticals: 2,500 shares worth $862K.
  • High Pointe Capital Management added most to AstraZeneca in Q2 2018, an estimated $493K increase.
  • High Pointe Capital Management's biggest Q2 2018 reduction was Alphabet (Google) Class C, cutting an estimated $75.6K.
  • High Pointe Capital Management fully exited Jones Lang LaSalle in Q2 2018, selling an estimated $1.34M.
  • High Pointe Capital Management's ten largest holdings make up 26% of its $70.1M portfolio in Q2 2018.
  • High Pointe Capital Management opened 5 new positions and closed 11 in Q2 2018.
  • High Pointe Capital Management's portfolio value fell 3.6% quarter-over-quarter to $70.1M.

Based on High Pointe Capital Management's 13F filing for Q2 2018, filed 8 Aug 2018.